Chronic Intestinal Pseudo-Obstruction
6
2
2
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
50%
1 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (6)
Velusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).
Safety and Efficacy of Endoscopic Full Thickness Biopsy in Patients With Chronic Intestinal Pseudo-obstruction
Indiana University Gastrointestinal Motility Diagnosis Registry
Pseudo-obstruction Assessment With MRI
Efficacy and Safety of Rifaximin for Patients With Chronic Intestinal Pseudo-obstruction: a Phase 2 Trial
Efficacy Study of Prucalopride to Treat Chronic Intestinal Pseudo-Obstruction (CIP)